MOL.LSE Molecule Group plc

Healthcare Pharmaceutical Retailers London Exchange
1.96 GBX
Close of Nov 3, 2026
190.55 284.00
Market cap
GBX 53.5M
P/E
-
P/B
1.23x
ROE
-12.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is MOL.LSE undervalued?

Graham number

The Graham number of Molecule Group plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Molecule Group plc fundamental analysis

No fundamental analysis for Molecule Group plc yet.

Molecule Group plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Molecule Group plc

Molecule Group plc operates as an investment company that focuses on acquiring companies or businesses in the ePharmacy market. The company was formerly known as Vulcan Two Group Plc and changed its name to Molecule Group plc in October 2026. The company was incorporated in 2025 and is based in London, United Kingdom.

Full company profile